The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma

Recent molecular classification of glioblastoma (GBM) has shown that patients with a mesenchymal (MES) gene expression signature exhibit poor overall survival and treatment resistance. Using regulatory network analysis of available expression microarray data sets of GBM, including The Cancer Genome...

Full description

Saved in:
Bibliographic Details
Main Authors: Bhat, Krishna P.L., Salazar, Katrina L., Balasubramaniyan, Veerakumar, Wani, Khalida, Heathcock, Lindsey, Hollingsworth, Faith, James, Johanna D., Gumin, Joy, Diefes, Kristin L., Kim, Se Hoon, Turski, Alice, Azodi, Yasaman, Yang, Yuhui, Doucette, Tiffany, Colman, Howard, Sulman, Erik P., Lang, Frederick F., Rao, Ganesh, Copray, Sjef, Vaillant, Brian D., Aldape, Kenneth D.
Format: Artigo
Language:Inglês
Published: Cold Spring Harbor Laboratory Press 2011
Subjects:
Research Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3248681/
https://ncbi.nlm.nih.gov/pubmed/22190458
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/gad.176800.111
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items